A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies
Peter R. Serafini(Boston Children's Hospital), Matthew S. Alexander(Children's of Alabama), Jeffrey J. Widrick(University of Massachusetts Chan Medical School), Rylie M. Hightower(Children's of Alabama), Genri Kawahara(Tokyo Medical University), Corinne E. Augelli‐Szafran(Southern Research Institute), Louis M. Kunkel(Boston Children's Hospital), Omar Moukha‐Chafiq(Southern Research Institute), Angela Lek(Muscular Dystrophy Association), Daniela Garcia-Perez(Children's of Alabama), Devin Gibbs(Boston Children's Hospital), Natássia M. Vieira(Boston Children's Hospital), Michael Feyder(Boston Children's Hospital)
Cited by 22
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|961
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
|Cell|2021|515
Distinctive patterns of microRNA expression in primary muscular disorders
|Proceedings of the National Academy of Sciences|2007|509
Life-long sustained mortality advantage of siblings of centenarians
|Proceedings of the National Academy of Sciences|2002|374
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
|Proceedings of the National Academy of Sciences|2002|365